Sarah James
Stock Analyst at Cantor Fitzgerald
(1.99)
# 3,040
Out of 5,161 analysts
306
Total ratings
34.8%
Success rate
-7.22%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UHS Universal Health Services | Maintains: Neutral | $250 → $229 | $190.49 | +20.22% | 28 | Feb 27, 2026 | |
| MDXG MiMedx Group | Maintains: Overweight | $12 → $8 | $4.38 | +82.65% | 1 | Feb 17, 2026 | |
| HUM Humana | Maintains: Neutral | $290 → $201 | $163.67 | +22.81% | 22 | Feb 12, 2026 | |
| MOH Molina Healthcare | Maintains: Neutral | $180 → $144 | $149.19 | -3.48% | 15 | Feb 9, 2026 | |
| CNC Centene | Reiterates: Neutral | $41 | $34.57 | +18.60% | 17 | Feb 9, 2026 | |
| HCA HCA Healthcare | Maintains: Overweight | $525 → $588 | $532.58 | +10.41% | 22 | Jan 28, 2026 | |
| ACHC Acadia Healthcare Company | Maintains: Neutral | $22 → $17 | $24.15 | -29.59% | 18 | Dec 3, 2025 | |
| CVS CVS Health | Maintains: Overweight | $78 → $95 | $76.07 | +24.88% | 16 | Oct 30, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $190 → $245 | $224.73 | +9.02% | 23 | Oct 29, 2025 | |
| SGRY Surgery Partners | Reiterates: Overweight | $36 | $12.74 | +182.57% | 13 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $4 | $1.79 | +123.46% | 8 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $440 | $277.05 | +58.82% | 18 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $365 | $265.88 | +37.28% | 22 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $28 | $17.50 | +60.00% | 15 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $485 | $287.89 | +68.47% | 20 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $29 | $17.56 | +65.15% | 6 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $15 | $3.94 | +281.19% | 11 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $5 | $0.62 | +710.24% | 8 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $10 | $5.36 | +86.57% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $133 | $153.06 | -13.11% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $42 | $21.27 | +97.46% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $8.33 | -39.98% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $7.00 | -28.57% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $17.12 | +22.66% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $59.78 | -34.76% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $193 | $74.97 | +157.44% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $3.24 | - | 2 | Mar 1, 2017 |
Universal Health Services
Feb 27, 2026
Maintains: Neutral
Price Target: $250 → $229
Current: $190.49
Upside: +20.22%
MiMedx Group
Feb 17, 2026
Maintains: Overweight
Price Target: $12 → $8
Current: $4.38
Upside: +82.65%
Humana
Feb 12, 2026
Maintains: Neutral
Price Target: $290 → $201
Current: $163.67
Upside: +22.81%
Molina Healthcare
Feb 9, 2026
Maintains: Neutral
Price Target: $180 → $144
Current: $149.19
Upside: -3.48%
Centene
Feb 9, 2026
Reiterates: Neutral
Price Target: $41
Current: $34.57
Upside: +18.60%
HCA Healthcare
Jan 28, 2026
Maintains: Overweight
Price Target: $525 → $588
Current: $532.58
Upside: +10.41%
Acadia Healthcare Company
Dec 3, 2025
Maintains: Neutral
Price Target: $22 → $17
Current: $24.15
Upside: -29.59%
CVS Health
Oct 30, 2025
Maintains: Overweight
Price Target: $78 → $95
Current: $76.07
Upside: +24.88%
Tenet Healthcare
Oct 29, 2025
Maintains: Overweight
Price Target: $190 → $245
Current: $224.73
Upside: +9.02%
Surgery Partners
Oct 7, 2025
Reiterates: Overweight
Price Target: $36
Current: $12.74
Upside: +182.57%
Oct 7, 2025
Reiterates: Neutral
Price Target: $4
Current: $1.79
Upside: +123.46%
Aug 26, 2025
Reiterates: Overweight
Price Target: $440
Current: $277.05
Upside: +58.82%
Aug 26, 2025
Reiterates: Overweight
Price Target: $365
Current: $265.88
Upside: +37.28%
Aug 8, 2025
Maintains: Overweight
Price Target: $26 → $28
Current: $17.50
Upside: +60.00%
Apr 23, 2025
Reiterates: Overweight
Price Target: $485
Current: $287.89
Upside: +68.47%
Mar 11, 2025
Maintains: Overweight
Price Target: $20 → $29
Current: $17.56
Upside: +65.15%
Mar 11, 2025
Reiterates: Overweight
Price Target: $15
Current: $3.94
Upside: +281.19%
Sep 20, 2024
Reiterates: Overweight
Price Target: $5
Current: $0.62
Upside: +710.24%
Aug 20, 2024
Reiterates: Overweight
Price Target: $10
Current: $5.36
Upside: +86.57%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $133
Current: $153.06
Upside: -13.11%
Aug 22, 2023
Reiterates: Overweight
Price Target: $42
Current: $21.27
Upside: +97.46%
Sep 15, 2022
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $8.33
Upside: -39.98%
Aug 19, 2022
Maintains: Overweight
Price Target: $7 → $5
Current: $7.00
Upside: -28.57%
Aug 8, 2022
Maintains: Overweight
Price Target: $14 → $21
Current: $17.12
Upside: +22.66%
Aug 12, 2021
Initiates: Overweight
Price Target: $39
Current: $59.78
Upside: -34.76%
Sep 15, 2017
Upgrades: Overweight
Price Target: $193
Current: $74.97
Upside: +157.44%
Mar 1, 2017
Downgrades: Underweight
Price Target: n/a
Current: $3.24
Upside: -